Over the past year there were no insider purchases at Bicycle Therapeutics plc. Eight insiders sold roughly $523,000 instead.
That's worth context: executives sell for plenty of routine reasons, from scheduled trading plans to tax bills. Buying is the rarer, more telling signal.
7 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters. On the institutional side, 104 funds reported holding BCYC at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Perry Jennifer Scott | COO | Sell | 30 | $3.57 | $107 | SEC |
| Oct 7, 2026 | Perry Jennifer Scott | COO | Sell | 326 | $3.78 | $1K | SEC |
| Oct 6, 2026 | Skynner Michael | Executive Officer | Sell | 503 | $3.57 | $2K | SEC |
| Oct 6, 2026 | Lee Kevin | CEO | Sell | 6,167 | $3.47 | $21K | SEC |
| Oct 6, 2026 | Hannay Michael Charles Ferguson | Executive Officer | Sell | 242 | $3.57 | $864 | SEC |
| Oct 6, 2026 | Perry Jennifer Scott | COO | Sell | 1,094 | $3.47 | $4K | SEC |
| Oct 6, 2026 | Skynner Michael | Executive Officer | Sell | 1,942 | $3.47 | $7K | SEC |
| Oct 6, 2026 | Lee Kevin | CEO | Sell | 1,638 | $3.57 | $6K | SEC |
| Oct 6, 2026 | Thompson Travis Alvin | CFO | Sell | 893 | $3.47 | $3K | SEC |
| Oct 6, 2026 | Thompson Travis Alvin | CFO | Sell | 79 | $3.57 | $282 | SEC |
| Oct 6, 2026 | Hannay Michael Charles Ferguson | Executive Officer | Sell | 1,572 | $3.47 | $5K | SEC |
| Oct 6, 2026 | Swanton Robert Charles | Director | Sell | 3,431 | $3.47 | $12K | SEC |
| Oct 6, 2026 | Perry Jennifer Scott | COO | Sell | 80 | $3.56 | $285 | SEC |
| Oct 6, 2026 | Perry Jennifer Scott | COO | Sell | 326 | $3.78 | $1K | SEC |
| Jul 7, 2026 | Thompson Travis Alvin | CFO | Sell | 104 | $4.31 | $448 | SEC |
In the last 12 months Bicycle Therapeutics plc insiders made open-market purchases worth about $0 and sales worth about $523,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in BCYC was filed on 2026-10-07.
104 investment managers reported holding BCYC in SEC Form 13F filings for Q2 2026.
No congressional trades in BCYC were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).